Articles:
Publications:

2 hours ago

There is still hope for Ebola treatment – DRC’s Muyembe

There is still hope for Ebola treatment – DRC’s Muyembe

Muyembe says his team will work with an American team to try to develop a monoclonal antibody against the Bundibugyo virus. As the number of Bundibugyo Ebola cases in the Democratic Republic of Congo (DRC) pushes past 1,000, doctors continue to... Read more.

More on this topic

Inter Press Service 4 hours ago
Turn on Transparency.
Ebola Outbreak Could Cost Africa $3.6 Billion and Threaten Nearly One Million Livelihoods
Owner: Inter Press Service (Non-profit, Fernando Morais Chair) More info
Independent (Uganda) 2 hours ago
Turn on Transparency.
There is still hope for Ebola treatment – DRC’s Muyembe
Owner: Andrew Mwenda More info
Sunday World 4 hours ago
Turn on Transparency.
Second batch of Chinese experts arrives in DRC to reinforce Ebola response
Owner: David Mabilu through Fundudzi Media More info
More

More from Independent (Uganda)

Independent (Uganda) 3 hours ago
Turn on Transparency.
Quality Chemical’s expansion problem
Owner: Andrew Mwenda More info
Independent (Uganda) 2 hours ago
Turn on Transparency.
Fiber wire mesh; The engineering is easier to fix than the economics
Owner: Andrew Mwenda More info
Independent (Uganda) 2 hours ago
Turn on Transparency.
There is still hope for Ebola treatment – DRC’s Muyembe
Owner: Andrew Mwenda More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

Jul. 3, 2026
What Is Happening to Climate Journalism?
Neutral | Owner: President & Fellows of Harvard College
Jul. 3, 2026
Brazil's Comics Journalism Is Growing Into a Bigger Speech Bubble
Center-left | Owner: The University of Texas at Austin

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more